loader2
Partner With Us NRI

Artemis Medicare Services Ltd share Price Today

Company details

177.59
183.85
96.15
199.90
6M Return 9.86%
1Y Return 83.18%
Mkt Cap.(Cr) 2,442.64
Volume 64,274
Div Yield 0.25%
OI
-
OI Chg %
-
Volume 64,274

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Healthcare Facilities company Artemis Medicare Services announced consolidated Q4FY24 & FY24 results:

Q4FY24 Financial Highlights:

  • Net Revenue from Operations increased by 15.3% to Rs 2,252 million from Rs 1,953 million
  • EBITDA increased by 42.1% to Rs 399 million from Rs 280 million
  • EBITDA margin at 17.7% compared to 14.4%
  • PAT increased by 33.6% to Rs 143 million from Rs 107 million, with margin of 6.4%
  • Net Debt of Rs 1,922 million as on 31st March 2024
  • Net Debt/Shareholder’s Equity of 0.42x

FY24 Financial Highlights:

  • Net Revenue from Operations of Rs 8,786 million compared to Rs 7,374 million, growth of 19.1%
  • EBITDA increased by 38.3% to Rs 1,401 million from Rs 1,013 million
  • EBITDA margin at 15.9% compared to 13.7%
  • PAT increased by 29.3% to Rs 491 million from Rs 380 million, with margin of 5.6%

Announcing the results, Dr. Devlina Chakravarty, Managing Director of Artemis Medicare Services, commented: "We are delighted to announce the strong performance of Q4FY24 and FY24, with growth across all major metrics. During the year, we fully operationalised the remaining beds in the second tower, helping us derive the benefits of economies of scale and improving our efficiencies. The construction of our third tower is also in the final stages, which, when operationalised, will enhance our financial and operational metrics. Additionally, as our asset light centres achieve maturity in the coming years, our consolidated performance will also improve. This year, we added a new centre under the Artemis Lite brand in Gurugram, catering to the New Gurugram area. The year also marked our presence overseas through the inauguration of the first hospital in Mauritius under Operations and Management agreement.

Operationally, we focused on refining the case mix and payer mix and improving financial parameters, resulting in one of the highest-ever ARPOBs in the industry. Our industry leading revenue share from international patients asserts our role and recognition as a trusted centre for Medical Value Travel. We have also extended our OPD timings in the evening to serve more salaried-class patients.

As part of our strategic growth initiatives, we are exploring expansion opportunities, which will help us leverage our brand, strengthen our presence in Northern India and act as a stepping stone to grow Artemis' presence in the region.

Looking ahead into FY25, we are confident to continue our robust performance and become one of the most well-regarded healthcare provider in India. We will continue to focus on clinical and non-clinical excellence, with innovative strategies and plans to expand our footprint, domestically and internationally."

Result PDF

View Other Company Results

Artemis Medicare Services Ltd shares SWOT Analysis

Strengths (8)

  • Company with high TTM EPS Growth
  • Effectively using its capital to generate profit - RoCE improving in last 2 years
  • Growth in Net Profit with increasing Profit Margin (QoQ)

Weakness (1)

  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (1)

  • Negative to Positive growth in Sales and Profit with Strong Price momentum

Threats (2)

  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 183.2
R2 186.7
R3 189.5
Pivot

180.41

S1 177.0
S2 174.2
S3 170.7
EMA SMA
178.6
178.9
175.9
162.9
177.9
181.8
177.6
168.4
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
Name Category Shares
CONSTRUCTIVE FINANCE PRIVATE LIMITED PROMOTER 68.03%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Artemis Medicare Services Ltd Stocks COMPARISON

Financials( in Cr) Artemis Medicare Services Ltd Max Healthcare Institute Ltd Apollo Hospitals Enterprise Ltd Fortis Healthcare Ltd Global Health Ltd
Price 179.79 927.90 6,207.60 502.25 1,356.20
% Change -1.10 4.25 0.02 3.99 6.17
Mcap Cr 2,442.64 90,183.71 89,255.98 37,917.77 36,414.92
Revenue TTM Cr 737.43 4,831.37 16,612.50 6,537.06 2,694.25
Net Profit TTM Cr 38.01 1,103.51 887.50 632.98 326.08
PE TTM 50.18 85.36 99.43 64.55 76.14
1 Year Return 83.18 60.94 25.38 74.57 116.27
ROCE 12.41 13.85 14.16 7.51 16.49
ROE 12.10 16.12 15.04 6.79 16.13
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 403.15 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 34,088.77 -1,030.79
LAST 3M 113,155.52 -39,495.50
LAST 6M 184,812.44 -13,263.60
LAST 12M 291,038.85 99,015.20

Artemis Medicare Services Ltd Information

Stock PE (TTM)
50.18
Promoter Holding
68.03%
Book Value
27.8314
ROCE
12.41%
ROE
12.1%
Description
  • Artemis Health Institute is a healthcare venture launched by the Promoters of the Apollo Tyres Group. Since incorporated in 18 May 2004, the Group is engaged in the business of managing and operating of multi specialty hospitals and commenced its commercial operation by setting up Artemis Hospital (formerly Artemis Health Institute) at Gurugram on 16 July 2007. Artemis Hospital (a unit of Artemis Medicare Services Limited) is spread across 9 acres, is a 395 bed; state-of-the-art multi-speciality hospital located in Gurugram, India. Designed as one of the most advanced in India, the Company provides a depth of expertise in the spectrum of advanced medical & surgical interventions, comprehensive mix of inpatient and outpatient services. Artemis Hospital diligently adheres to meet the highest standards of clinical outcomes which it has set for itself in various specialties. The Hospital is the first to introduce Masimo technology based on Clinical Surveillance System and equipped with North India`s first M6 Cyber knife having successfully performed over 1000 procedures. The hospital has an impeccable track record and high success rates even in surgeries of high complexity such as transplants, cardiac care and oncology. This unwavering focus on clinical excellence enables Artemis Hospitals to continuously assess the quality of care provided to patients and allows to objectively measure the consistency and success of healthcare delivery services. In addition to the focus on clinical excellence, the Hospital ensures that medical professionals and other staff are periodically trained on the newest techniques and procedures in the medical field on a periodic and continuous basis. The Hospital has put modern technology in the hands of renowned doctors from India and abroad as well to set new standards in healthcare. The medical practices and procedures followed in the hospital are research oriented and bench-marked against the best in the world. Top-notch services, in a warm, open patient centric environment, clubbed with affordability, has made the Unit one of the most revered hospitals in the country. Artemis Hospital received accreditation from the Joint Commission International, USA (JCI) for meeting international healthcare quality standards for patient care and management. The Hospital in Gurugram was accredited with JCI and NABH (National Accreditation Board for Hospitals) within 3 years of start up. The hospital also received Green OT certification from Bureau Veritas.

Registered Address

Plot No 14 Sector 20, Dwarka, New Delhi, Delhi, 110075

Tel : 91-11-4511111
Email : investor:artemishospitals.com
Website : http://www.artemishospitals.com
Registrar

Alankit Assignments Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 542919
NSE Code : ARTEMISMED
Book Closure Date (Month) :
BSE Group : B
ISIN : INE025R01021

FAQ’s on Artemis Medicare Services Ltd Shares

You can buy Artemis Medicare Services Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Artemis Medicare Services Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 14, 2024 03:55 PM the closing price of Artemis Medicare Services Ltd was Rs.179.79.

The latest PE ratio of Artemis Medicare Services Ltd as of Jun 14, 2024 03:55 PM is 50.18

The latest PB ratio of Artemis Medicare Services Ltd as of Jun 14, 2024 03:55 PM is 0.15

The 52-week high of Artemis Medicare Services Ltd share price is Rs. 199.90 while the 52-week low is Rs. 96.15

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 14, 2024 03:55 PM, the market cap of Artemis Medicare Services Ltd stood at Rs. 2,442.64.

Download App

Download Our App

Play Store App Store
market app